Dissecting the Conformational Flexibility of HIV-1 Envelope Glycoproteins
Dissecting the Conformational Flexibility of HIV-1 Envelope Glycoproteins
批准号:
10646287
负责人:
Alon Herschhorn
金额:
$57.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-15 至 2027-05-31
关键词:
AdoptedAffectAmino AcidsAntibodiesAntibody TherapyAntigensArchivesBindingBinding SitesBiologyCellsComplexCryoelectron MicroscopyDevelopmentElectronsElementsEpitopesEvolutionGenerationsGlycoproteinsGoalsHIVHIV Envelope Protein gp120HIV InfectionsHIV envelope proteinHIV-1HIV-1 vaccineHeterogeneityInpatientsKineticsKnowledgeMapsMeasuresMediatingModelingMolecularMolecular ConformationMutationPathway interactionsPatientsPersonsPreventive vaccineProbabilityPublishingResolutionShapesSourceSpectrum AnalysisStructureTestingTherapeutic InterventionTimeTranslatingV3 LoopVaccine DesignVaccinesVariantViralVirusWorkdesignflexibilityimprovedin vivoinsightlatent HIV reservoirneutralizing antibodypandemic diseasepreventive interventionresistant strainsingle-molecule FRETtargeted treatmenttherapeutic developmenttransmission processworking group
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
HIV-1 envelope glycoproteins (Envs) mediate viral entry into host cells and are the sole target of neutralizing
antibodies. HIV-1 Envs of most primary HIV-1 strains typically exist in a closed conformation (State 1) and
occasionally transit to downstream, more open conformations (State 2 and State 3). Thus, current knowledge
guides immunogen design towards mimicking the Env closed conformation as the preferred target for eliciting
broadly neutralizing antibodies (bnAbs) to block HIV-1 entry. However, Env preferred conformations of more
than 37 million different circulating HIV-1 strains are unlikely to adopt exactly the same closed conformation. And
we still do not know how different State 1 conformations of diverse natural HIV-1 variants are.
Our hypothesis: State 1 Envs form a heterogenous group of Envs that exist in similar but not identical
conformations. Accordingly, improved ability of bnAbs to recognize multiple Env conformations will
broaden their neutralization activity.
To test our hypothesis, we will assess the conformational heterogeneity of Envs from different strains and build
mechanistic models for 1) Envs transitions, 2) generation and transmission of Envs that exist in specific
conformations, and 3) broad recognition of different Env states. In Specific Aim 1 we will study the conformational
diversity of transmitted/founder (T/F) HIV-1 strains, which can establish HIV-1 in vivo and are the only target of
a preventive vaccine. We will study the mechanisms by which T/F Envs expose internal elements and how they
transit to downstream conformations. In Specific Aim 2 we will investigate the generation and evolution of
incompletely closed Env conformation. We will reconstruct the evolution pathway of T/Fs in patients by using
available viral sequences to build evolved viruses at different time point followed by investigating changes in
their conformational states over time. In parallel, we will study Env conformational diversity among HIV-1 strains
that are archived in the latent HIV-1 reservoir of people living with HIV-1 and identify potential targets for
therapeutic interventions. These approaches will allow us to build a mechanistic model for how incompletely
closed Envs are generated, evolved, and transmitted. In Specific Aim 3 we will define important parameters for
broad recognition of CD4-binding site (CD4-bs) on different Env conformations of diverse primary strains. We
will study how the exceptionally broad N6 (CD4-bs) bnAb recognizes different Env conformations, will identify
critical interactions with residues on open and closed Env conformations, and will solve cryo-EM structures of
HIV-1 Envs in complex with N6 to define the mechanism of broad recognition.
Overall, our study will provide high-resolution and comprehensive view on the biology of HIV-1 entry pathway,
will refine the knowledge on HIV-1 Env conformations, and will form a strong basis for the development of new
strategies for HIV-1 cure and vaccine design.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the Conformational Flexibility of HIV-1 Envelope Glycoproteins
-
批准号:10546775
-
项目类别:
-
资助金额:$60.62万
-
财政年份:2022
-
负责人:Alon Herschhorn
-
依托单位:
海外基金